10hon MSN
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...
By Sriparna Roy and Padmanabhan Ananthan Feb 24 (Reuters) - Novo Nordisk will slash U.S. list prices of its blockbuster ...
The reductions will also apply to pill versions of the drugs, including Rybelsus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results